IntraCytoplasmic Sperm Injection (ICSI)

ICSI (intracytoplasmic sperm injection) has revolutionized IVF because it has allowed us to offer treatment to men for whom no treatment was available. Not only will it help couples in whom the male has just a few, barely swimming sperm in the ejaculate, but thanks to advanced techniques for aspirating sperm from the ductal system and techniques to harvest sperm from testicular biopsies, it can also aid men who ejaculate no sperm. These sperm-harvesting techniques include MESA (microsurgical epididymal sperm aspiration) and PESA (percutaneous epididymal sperm aspiration), a procedure where sperm can be obtained by passing a tiny needle through the skin into the epididymis. Testicular sperm extraction (TESE) is also a procedure, done with a large biopsy needle under local or general anesthesia. The IVF cycle is conducted exactly in the manner described above with a very few exceptions. After the eggs are retrieved, instead of mixing the sperm with the egg, the embryologist utilizes a thin glass pipette to immobilize a slightly mobile sperm, sucks it up into the pipette, and then injects it directly into the egg’s cytoplasm. Since the egg is the size of a pinpoint, it is a sophisticated technique requiring a high-powered microscope, tiny glass pipettes, and instruments that translate hand movements into extremely fine movements of the pipettes.

“FERTILITY MAY HAVE CHALLENGED US, BUT WE ARE STRONGER FOR IT.”

The success rate for IVF with ICSI is about the same as for IVF, indicating that the manipulation has very little effect on the egg. However, since the female partners of these men are often reproductively normal, there may be some small adverse effect, also reflected in reports of slightly reduced embryo quality with ICSI. Most data indicate similar rates of congenital abnormalities with the general population and IVF without ICSI, although some reports suggest a minor increase of chromosomal anomalies, many of which are related to the man’s genetics or his sperm, rather than the procedure itself. Because of these concerns, prenatal genetic testing with a fetal karyotype is suggested for ICSI pregnancies. In a proportion of men (10 to 20 percent) with very low or absent sperm in the ejaculate, the man may have a chromosome defect or a genetic defect not visible on routine chromosome analysis (Y chromosome microdeletion) that could pass on a similar problem with infertility to male offspring. Rarely, such a chromosome defect could cause a serious abnormality in the offspring. Therefore, suggest a pre-cycle karyotype for men with fewer than 5-10 million sperm per ml in the ejaculate.


 
Close Menu
× How can we help you?